The regulatory milestone enables the use of Medtronic’s trusted vessel sealing technology on its Hugo™ robotic-assisted surgery platform, enhancing precision and expanding clinical versatility across Europe. ...
FDA-cleared Magnetic-Assisted Robotic Surgery (MARS™) platform achieves major clinical milestone, signaling growing adoption and impact in abdominal procedures across U.S. centers. ...
The recognition underscores FastWave’s rising prominence in intravascular lithotripsy, as the company expands its intellectual property portfolio and momentum in cardiovascular innovation. ...
Strategic combination aims to accelerate innovation and scale in regulated, high-volume testing markets across pharma, clinical diagnostics, and life sciences....
New MicroTip™ Partnership Assays Enhance Automated Gastrointestinal Testing Capabilities on VITROS™ Platforms...
Non-Invasive Histotripsy Treatment Now Accessible to 7 Million Blue Cross Blue Shield Highmark Members Across U.S....
Definitive agreement strengthens Zimmer Biomet’s position in orthopedic innovation by integrating autonomous robotic technology into its surgical solutions suite....
Company Welcomes Milestone Toward Expanding Medicare Access to Innovative Renal Denervation Therapy for Uncontrolled Hypertension...
With dozens of approved devices across neurology, orthopaedics, and radiology, the FDA underscores its commitment to guiding safe, innovative integration of augmented and virtual reality in healthcare...
Spanning Radiology, Cardiology, Neurology, and More, the List Highlights FDA’s Ongoing Commitment to Advancing Safe and Effective AI Integration in Healthcare...
